Private Prescription Access: Mounjaro vs Wegovy Comparison
Private Prescription Route: What Makes Mounjaro vs Wegovy Different
When considering what is best Mounjaro or Wegovy through private prescription, the key difference lies in their mechanisms of action and availability routes. Wegovy (semaglutide) is a GLP-1 receptor agonist that's available through both NHS specialist weight management services and private prescription, whilst Mounjaro (tirzepatide) combines GIP and GLP-1 receptor targeting as a dual agonist. The private prescription route eliminates the need for GP referrals and specialist weight management service waiting lists, which can extend beyond six months on the NHS. Both medications require clinical assessment and ongoing monitoring, but private prescriptions allow for faster access to treatment.
The practical advantage of private prescription becomes clear when comparing timelines: NHS patients typically wait for GP referral, then specialist assessment, followed by potential medication access after meeting strict criteria. Private prescription patients can complete a clinical assessment online and receive prescriber review within 24-48 hours. EverydayMeds provides both options through our GPhC-registered pharmacy (#9012878), ensuring you receive genuine manufacturer medications with proper clinical oversight.
Wegovy Pricing Structure and Value for Private Prescription
Understanding what is best Mounjaro or Wegovy often comes down to pricing transparency and accessibility. Wegovy follows a mandatory dose escalation schedule: 0.25mg (£79.99) for weeks 1-4, 0.5mg (£94.99) for weeks 5-8, 1mg (£99.99) for weeks 9-12, 1.7mg (£139.99) for weeks 13-16, and 2.4mg maintenance (£209.99) from week 17 onwards. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25. Our bundle options provide convenience for multi-month supply, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg maintenance pens) for £649.99.
The cost of private prescription must be weighed against NHS availability and waiting times. Whilst NHS prescription charges are significantly lower, accessing specialist weight management services requires meeting specific BMI criteria and often involves lengthy waiting periods. Private prescription provides immediate access to the same prescription-only medicine with transparent pricing and no hidden costs. All prices include clinical assessment, prescriber review, and next-day cold-chain delivery to maintain medication integrity.
Clinical Evidence: Wegovy vs Mounjaro Trial Data
When evaluating what is best Mounjaro or Wegovy based on clinical evidence, both medications have demonstrated significant efficacy in their respective trial programmes. Wegovy's STEP trial programme, including the landmark study by Wilding et al., NEJM, 2021, showed participants achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events. These results represent outcomes in clinical trial conditions and individual results may vary considerably.
Mounjaro's SURMOUNT trials have shown promising results for the dual GIP/GLP-1 approach, though direct head-to-head comparisons aren't available due to different trial designs, populations, and endpoints. Both medications work as prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity. Your prescriber can help determine which mechanism of action may be more suitable for your individual circumstances and medical history.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding what is best Mounjaro or Wegovy requires knowing how Wegovy's GLP-1 mechanism functions in weight management. Wegovy (semaglutide) mimics the action of GLP-1, a natural hormone released by the intestine after eating that signals satiety to the brain. This mechanism may help reduce appetite, promote feelings of fullness after smaller meals, and potentially reduce food cravings by acting on brain appetite centres. The once-weekly injection delivers consistent medication levels, maintaining these appetite-regulating effects throughout the week. Unlike oral medications that require daily dosing, Wegovy's extended-release formulation provides convenience and consistent therapeutic levels that may support better treatment adherence.
Streamlined Ordering Process for Private Prescription
The private prescription process for determining what is best Mounjaro or Wegovy begins with our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Your responses are reviewed by our qualified prescribers, typically within 3 working days (or 24 hours with express review). Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using temperature-controlled packaging to maintain medication integrity. This streamlined approach eliminates the traditional barriers of GP appointments, referral waiting times, and specialist clinic availability that characterise the NHS route.
Storage and Practical Considerations: Wegovy Advantages
Practical factors often influence what is best Mounjaro or Wegovy for individual patients, particularly around storage and travel convenience. Wegovy offers superior storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications use pre-filled FlexTouch pens for once-weekly subcutaneous injection, but Wegovy's extended room temperature stability provides advantages for travel, work schedules, or temporary fridge unavailability. The dose escalation schedule is mandatory for both medications, starting at the lowest dose to minimise gastrointestinal side effects and gradually increasing to therapeutic levels over 16 weeks before reaching maintenance dosing.
Dual Mechanism vs Single Target: Understanding the Difference
The fundamental difference when considering what is best Mounjaro or Wegovy lies in their receptor targeting approaches. Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors, potentially offering enhanced metabolic effects through dual hormone pathway stimulation. This dual mechanism may provide additional benefits in glucose regulation and weight management, though long-term comparative data remains limited. Wegovy's single GLP-1 targeting has extensive long-term safety data and established cardiovascular benefits demonstrated in the SELECT trial.
Both approaches require careful consideration of individual patient factors, medical history, and treatment goals. Some patients may respond better to single-target therapy, whilst others might benefit from the dual mechanism approach. Neither medication can be considered universally superior, as effectiveness depends on individual physiology, adherence, and concurrent lifestyle modifications. Both medications are available through EverydayMeds' private prescription service, allowing your prescriber to recommend the most appropriate option based on your specific circumstances.
Complete Your Private Prescription Journey Today
Deciding what is best Mounjaro or Wegovy through private prescription doesn't have to be overwhelming when you have expert guidance and transparent pricing. EverydayMeds offers both medications through our streamlined assessment process, with new customers using code FIRST40 and returning customers applying DOSE25 at checkout. Our qualified prescribers will review your assessment and recommend the most suitable option based on your individual needs, medical history, and treatment goals. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy and take the first step towards accessing prescription-only weight management medication without the delays of NHS waiting lists. Remember that both medications work best alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management approach.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
